Abha Kundi*’s Insights

24 total results. Page 1 of 2.

Alerts
AI Do: Why the FDA Wants Your Input on AI in Clinical Trials (and Why You Should Give It)
Events
Webinar: From Serial Numbers to Supply Chain Security
Longevity Lens
The Shot Heard ‘Round the Pharmacy’: FDA Takes Aim at GLP-1 Compounders
Longevity Lens
The Amino-zing World of Peptide Regulation
Alerts
All Filler, No Foundation: Pure Indulgence’s 483 Becomes a DSCSA Warning Letter
Longevity Lens
The Brain-Computer Interface Race Is On – Is the Law Ready?
Events
2026 Chicago Pharma Forum
Alerts
Navigating the 2026 Life Sciences Legal Landscape
Alerts
NDSee You in 2033: FDA’s 12‑Digit NDC Is Coming
Health Care Counsel Blog
CMS ACCESS Model Update: Payment Rates and Performance Targets Released for 2026–2027
Longevity Lens
The Regulatory Roadmap: Five Critical Questions for Evaluating Regulatory Risk for Longevity Companies
Longevity Lens
The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss